In vivo micro-computed tomography evaluation of radiopaque, polymeric device degradation in normal and inflammatory environments
Acta Biomaterialia · 2024-06 · 181 · 222-234
DOI: 10.1016/j.actbio.2024.04.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-06. Verfasst von Kendell M Pawelec und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Michigan State University, East Lansing, MI 48824, USA; Institute for Quantitative Health Sciences and Engineering, Michigan…. Hauptthemen laut MEDLINE: Inflammation, X-Ray Microtomography, Contrast Media. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIGMS NIH HHS, NIBIB NIH HHS, NIH HHS.
Abstract (Originalsprache)
Polymeric biomedical implants are an important clinical tool, but degradation remains difficult to determine post-implantation. Computed tomography (CT) could be a powerful tool for device monitoring, but polymers require incorporation of radiopaque contrast agents to be distinguishable from tissue. In addition, immune response to radiopaque devices must be characterized as it modulates device function. Radiopaque devices and films were produced by incorporating 0-20 wt% TaOx nanoparticles into polymers: polycaprolactone (PCL) and poly(lactide-co-glycolide) (PLGA). In vitro inflammatory responses of mouse bone marrow-derived macrophages to polymer matrix incorporating TaOx nanoparticles was determined by monitoring cytokine secretion. Nanoparticle addition stimulated a slight inflammatory reaction, increasing TNFα secretion, mediated by changes in polymer matrix properties. Subsequently, devices (PLGA 50:50 + 20 wt% TaOx) were implanted subcutaneously in a mouse model of chronic inflammation, that featured a sustained increase in inflammatory response local to the implant site over 12 weeks. No changes to device degradation rates or foreign body response were noted between a normal and chronically stimulated inflammatory environment. Serial CT device monitoring post-implantation provided a detailed timeline of device collapse, with no rapid, spontaneous release of nanoparticles that occluded matrix visualization. Importantly, repeat CT sessions did not ablate the immune system or alter degradation kinetics. Thus, polymer devices incorporating radiopaque nanoparticles can be used for in situ monitoring and be readily combined with other medical imaging techniques, for a dynamic view biomaterial and tissue interactions. STATEMENT OF SIGNIFICANCE: A growing number of implantable devices are in use in the clinic, exposing patients to inherent risks of implant movement, collapse, and infection. The ability to monitor implanted devices would enable faster diagnosis of failure and open the door for personalized rehabilitation therapies - both of which could vastly improve patient outcomes. Unfortunately, polymeric materials which make up most biomedical devices are not radiologically distinguishable from tissue post-implantation. The introduction of radiopaque nanoparticles into polymers allows for serial monitoring via computed tomography, without affecting device degradation. Here we demonstrate for the first time that nanoparticles do not undergo burst release from devices post-implantation and that inflammatory responses - a key determinant of device function in vivo - are also unaffected by nanoparticle addition.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, Michigan State University, East Lansing, MI 48824, USA; Institute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, MI 48824, USA. Electronic address: pa…
- Department of Radiology, Michigan State University, East Lansing, MI 48824, USA; Institute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, MI 48824, USA.
- Department of Radiology, Michigan State University, East Lansing, MI 48824, USA.
- Quantitative Bio Element Analysis and Mapping (QBEAM) Center, Michigan State University, East Lansing, MI 48824, USA.
- Department of Pathobiology and Diagnostic Investigation, Michigan State University, East Lansing, MI 48824, USA.
- Department of Radiology, Michigan State University, East Lansing, MI 48824, USA; Institute for Quantitative Health Sciences and Engineering, Michigan State University, East Lansing, MI 48824, USA; Department of Physiolo…
Förderung
- NIGMS NIH HHS
- NIBIB NIH HHS
- NIH HHS
- National Institute of Biomedical Imaging and Bioengineering
- Office of the Director
- Michigan State University
- National Institutes of Health
- NIH Office of the Director
Zitieren
APA
Pawelec, K. M., Hix, J. M. L., Troia, A., MacRenaris, K. W., Kiupel, M., & Shapiro, E. M. (2024). In vivo micro-computed tomography evaluation of radiopaque, polymeric device degradation in normal and inflammatory environments. Acta Biomaterialia, 181, 222-234. https://doi.org/10.1016/j.actbio.2024.04.031
Vancouver
Pawelec KM, Hix JML, Troia A, MacRenaris KW, Kiupel M, Shapiro EM. In vivo micro-computed tomography evaluation of radiopaque, polymeric device degradation in normal and inflammatory environments. Acta Biomaterialia. 2024;181:222-234. doi:10.1016/j.actbio.2024.04.031
BibTeX
@article{Pawelec2024,
author = {Pawelec, Kendell M and Hix, Jeremy M L and Troia, Arianna and MacRenaris, Keith W and Kiupel, Matti and Shapiro, Erik M},
title = {In vivo micro-computed tomography evaluation of radiopaque, polymeric device degradation in normal and inflammatory environments},
journal = {Acta Biomaterialia},
year = {2024},
volume = {181},
pages = {222--234},
doi = {10.1016/j.actbio.2024.04.031}
}
EUVIMED